Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College Hospital, The Ministry of Education Key Laboratory, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China, 100730; Clinical Immunology Centre, Medical Epigenetics Research Centre, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 100730.
Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College Hospital, The Ministry of Education Key Laboratory, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China, 100730; Clinical Immunology Centre, Medical Epigenetics Research Centre, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 100730.
Trends Mol Med. 2020 Sep;26(9):862-873. doi: 10.1016/j.molmed.2020.04.001. Epub 2020 May 10.
The pathogenesis of autoimmune diseases (AIDs) is not only attributed to genetic susceptibilities but also environmental factors, among which, disturbed gut microbiota has attracted increasing attention. Compositional and functional changes of gut microbiota have been reported in various AIDs, and increasing evidence suggests that disturbed gut microbiota contributes to their immunopathogenesis. The accepted mechanisms include abnormal microbial translocation, molecular mimicry, and dysregulation of both local and systemic immunity. Studies have also suggested microbiota-based classification models and therapeutic interventions for patients with AIDs. Further in-depth mechanistic studies on microbiota-autoimmunity interplay in AIDs are urgently needed and underway to explore novel and precise diagnostic biomarkers and develop disease and patient-tailored therapeutic strategies.
自身免疫性疾病(AIDs)的发病机制不仅归因于遗传易感性,还归因于环境因素,其中,肠道菌群失调引起了越来越多的关注。在各种自身免疫性疾病中,已经报道了肠道菌群的组成和功能变化,越来越多的证据表明,肠道菌群失调有助于其免疫发病机制。公认的机制包括异常的微生物易位、分子模拟和局部及全身免疫的失调。研究还提出了基于微生物组的分类模型和治疗干预措施,用于治疗自身免疫性疾病患者。目前迫切需要对自身免疫性疾病中微生物组-自身免疫相互作用进行更深入的机制研究,以探索新的、精确的诊断生物标志物,并制定针对疾病和患者的治疗策略。